BiotechTube
Home/Evox Therapeutics/Per Lundin, PhD
PL

Per Lundin, PhD

Co-founder & Chief Executive Officer

Evox Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesNeurodevelopmental Disorders

Evox Therapeutics Pipeline

DrugIndicationPhase
ExoEdit® for Rett SyndromeRett SyndromePre-clinical

Leadership Team at Evox Therapeutics

DT
Douglas Treco, PhD
Board Member
View full Evox Therapeutics profile